Your browser doesn't support javascript.
loading
A Case of Squamous Cell Carcinoma of Unknown Primary that Responded to the Multi-Tyrosine Kinase Inhibitor Lenvatinib.
Kimura-Tsuchiya, Reiko; Sasaki, Eisaku; Nakamura, Izumi; Suzuki, Satoshi; Kawana, Satoshi; Okouchi, Chiyo; Fukushima, Toshihiko; Hashimoto, Yuko; Suzuki, Shinichi; Saji, Shigehira.
  • Kimura-Tsuchiya R; aDepartment of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Sasaki E; aDepartment of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Nakamura I; bDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
  • Suzuki S; bDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
  • Kawana S; cDepartment of Diagnostic Pathology, Fukushima Medical University, Fukushima, Japan.
  • Okouchi C; bDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
  • Fukushima T; bDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
  • Hashimoto Y; cDepartment of Diagnostic Pathology, Fukushima Medical University, Fukushima, Japan.
  • Suzuki S; bDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
  • Saji S; aDepartment of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
Case Rep Oncol ; 11(1): 75-80, 2018.
Article en En | MEDLINE | ID: mdl-29515414
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2018 Tipo del documento: Article